A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition: Healthy Interventions: Drug: Dabigatran etexilate (DE); Drug: Rosuvastatin; Drug: PF-07081532 Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Crestor | Eating Disorders & Weight Management | Obesity | Pfizer | Pradaxa | Research | Rosuvastatin | Study